Evidence map›Paper›PMID 41677627›Full record

ArticleCells2026

Chitinase-like Proteins YKL-40 and YKL-39 in Colorectal Cancer.

Tsvetomira Ivanova, Maria Kazakova, Dorian Dikov, Angel M Dzhambov, Nikolay Belev, Boyko Atanasov, Victoria Sarafian

Abstract read
In one paragraph

Article in Cells, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Tsvetomira IvanovaDepartment of Medical Biology, Medical University-Plovdiv, 4002 Plovdiv, Bulgaria.ORCID 0000-0001-7778-0445
Maria KazakovaDepartment of Medical Biology, Medical University-Plovdiv, 4002 Plovdiv, Bulgaria.
Dorian DikovDepartment of Pathology, Jossigny Hospital, 75000 Jossigny, France.
Angel M DzhambovEnvironmental Health Division, Research Institute at Medical University-Plovdiv, 4002 Plovdiv, Bulgaria.ORCID 0000-0003-2540-5111
Nikolay BelevDepartment of Propaedeutics of Surgical Diseases, Medical University-Plovdiv, University Hospital Eurohospital, 4002 Plovdiv, Bulgaria.
Boyko AtanasovResearch Institute at Medical University-Plovdiv, 4000 Plovdiv, Bulgaria.
Victoria SarafianDepartment of Medical Biology, Medical University-Plovdiv, 4002 Plovdiv, Bulgaria.ORCID 0000-0003-1501-0175

Funding

Bulgarian National Science Fund КП-06-Н63/8 from13.12.2022European Union-NextGenerationEU BG-RRP-2.004-0007-C01
6 · The paper itself

Abstract

YKL-40 and YKL-39 chitinase-like proteins (CLPs) are secreted glycoproteins involved in inflammation, macrophage polarization, and carcinogenesis. Their expression is significantly upregulated in various inflammatory and immunological conditions, including several cancers, suggesting a role as potential diagnostic markers. Colorectal cancer (CRC) remains a significant global health concern, with a continued need for reliable biomarkers to stratify patients and predict therapy response. In this study, we assessed tissue, plasma, and transcript levels of both CLPs in CRC. We found a strong association between their tissue expression and tumor budding. Notably, plasma YKL-39 levels were lower in CRC patients than in controls, while YKL-40 concentrations were higher in the patient group. Gene expression analysis for both CLPs in white blood cells (WBCs) did not reveal statistical significance between CRC patients and controls. These findings enhance our understanding of the clinical relevance of these molecular signatures and support their potential application as biomarkers in CRC stratification.

Indexed as

Chitinase-3-Like Protein 1Colorectal NeoplasmsAgedBiomarkers, TumorFemaleGene Expression Regulation, NeoplasticHumansMaleMiddle AgedBiomarkers, TumorCHI3L1 protein, humanChitinase-3-Like Protein 1CRCliquid biopsytumor buddingYKL-39YKL-40

Identifiers

PMID41677627
PMCPMC12971110

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.